HealthQuill Pharma
Max Healthcare, one of India’s largest private hospital chains, reported a 7% rise in profit after tax, on revenue of INR 15.6 billion, as average per occupied bed and international patient revenues jumped.
Drugs Medical Pharma

Max Healthcare profit jumps 7%, to raise INR 42 billion in debt

Max Healthcare, one of India’s largest private hospital chains, reported a 7% rise in profit after tax, on revenue of INR 15.6 billion,.

Read More
Fizzy drinks, mass-produced breads, many ready meals, and most breakfast cereals increase the risk of cancer as they contain higher salt, fat, sugar and artificial additives, a UK study revealed.
Health Medical Pharma

Junk food increase ovarian, brain cancer risk: UK study

Fizzy drinks, mass-produced breads, many ready meals, and most breakfast cereals increase the risk of cancer as they contain higher salt, fat, sugar.

Read More
Twelve African nations have drawn out a blueprint to stop AIDS in children by 2030, a move welcomed by the United Nations.
Drugs Medical Pharma

12 African nations commit to end AIDS in children by 2030

Twelve African nations have drawn out a blueprint to stop AIDS in children by 2030, a move welcomed by the United Nations.

Read More
Stelis Biopharma, a division of India’s Strides Pharma Science, will become a full-fledged contract development and manufacturing firm and may list “near-term.
Drugs Health Pharma

Stelis Biopharma to be pure play CDMO firm, may list ‘near term’

Stelis Biopharma, a division of India’s Strides Pharma Science, will become a full-fledged contract development and manufacturing firm and may list “near-term.

Read More
Glenmark Pharmaceuticals, an Indian global drug maker with a focus on dermatology, respiratory and oncology areas, forecasts lifting of China's COVID-19 curbs may ease disruptions in the supply chain situation.
Drugs Medical Pharma

China’s lifting of COVID-19 curbs to ease supply chain disruptions: Glenmark

Glenmark Pharmaceuticals, an Indian global drug maker with a focus on dermatology, respiratory and oncology areas, forecasts lifting of China's COVID-19 curbs may.

Read More
The Indian pharmaceutical market is estimated to be worth $130 billion by 2030 from an estimated US$ 41 billion in 2021, the Economic Survey, a government report, stated.
Drugs Pharma

India’s pharma market to be worth $130 billion by 2030

The Indian pharmaceutical market is estimated to be worth $130 billion by 2030 from an estimated US$ 41 billion in 2021, the Economic.

Read More
Syngene's operations in the Indian city of Hyderabad have been transferred to another wholly-armed arm of the company with effect from April 1, 2023, for a value of INR 4 billion, according to a BSE filing.
Drugs Pharma

Syngene buys Hyderabad operations in slump sale value of INR 4 billion

Syngene's operations in the Indian city of Hyderabad have been transferred to another wholly-armed arm of the company with effect from April 1,.

Read More
The U.S. plans to end COVID-19 emergency restrictions by May 11, according to a statement by the Office of Management and Budget.
Health Medical Pharma

U.S. to end Covid-19 curbs on May 11, migrant policy remains same

The U.S. plans to end COVID-19 emergency restrictions by May 11, according to a statement by the Office of Management and Budget.

Read More
Lupin, headquartered in Mumbai, India, has received tentative approval from the FDA under the US President’s Emergency Plan for AIDS Relief for its New Drug Application for three drugs.
Drugs Medical Pharma

Lupin gets tentative nod for three HIV drugs

Lupin, headquartered in Mumbai, India, has received tentative approval from the FDA under the US President’s Emergency Plan for AIDS Relief for its.

Read More
Pfizer refuted allegations by Project Veritas, a media organization, in its ongoing COVID-19 vaccine work stating it has “not conducted gain-of-function” or “directed evolution research.”
Drugs Medical Pharma

No ‘directed evolution research’ in COVID-19 vaccine: Pfizer

Pfizer refuted allegations by Project Veritas, a media organization, in its ongoing COVID-19 vaccine work stating it has “not conducted gain-of-function” or “directed.

Read More